Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...

Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...

Lilly, Johnson & Johnson, Novartis and AstraZeneca have now announced manufacturing investments in the U.S., trying to ...

As trade tensions between the US and China escalate, a small-cap ASX biotech could become a strategic gateway for bringing ...

Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...

Cassava Sciences said its chief medical officer, Dr. James Kupiec, is retiring, effective May 9. Under Kupiec, the clinical-stage biotechnology company completed a clinical trial program in ...

Several states are reporting cases of measles, a highly contagious viral disease. Both children and adults can get measles.

In line with its vision to establish the world’s first true learning health system, Announced at Abu Dhabi Global Health Week ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences ...

Single and multi-dose studies of the small molecule TREM2 agonist VG-3927 clear early safety hurdle. Meanwhile, new findings ...

Let us temper our criticism with kindness. None of us comes fully equipped.”– Carl Sagan, The Demon-Haunted WorldThis month’s ...

Photo: Alamy President Donald Trump discussed the impact of his recent tariffs on Sunday, calling on other nations to “build ...